Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review-Reference-Cited by-同舟云学术

Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review

Published:2022-08-09 Issue:8 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kreuzberger Nina¹,Hirsch Caroline¹,Andreas Marike¹,Böhm Lena²,Bröckelmann Paul J³⁴,Di Cristanziano Veronica⁵,Golinski Martin⁶,Hausinger Renate Ilona⁷,Mellinghoff Sibylle³⁸,Lange Berit⁹¹⁰,Lischetzki Tina¹,Kappler Verena⁷,Mikolajewska Agata¹¹¹²,Monsef Ina¹,Park Yun Soo¹,Piechotta Vanessa¹,Schmaderer Christoph⁷,Stegemann Miriam¹¹,Vanshylla Kanika⁵,Weber Florencia²,Weibel Stephanie²,Stephani Caspar⁶,Skoetz Nicole¹

Affiliation:

1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

2. Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany

3. Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD); Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

4. Max-Planck Institute for the Biology of Ageing; Cologne Germany

5. Laboratory of Experimental Immunology, Institute of Virology; University Hospital of Cologne; Cologne Germany

6. Department of Anesthesiology; University of Goettingen Medical Center; Goettingen Germany

7. Department of Nephrology; Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich; Munich Germany

8. German Centre for Infection Research (DZIF); partner site Bonn-Cologne Germany

9. Department of Epidemiology; Helmholtz Centre for Infection Research; Brunswick Germany

10. Translational Unit BBD; German Center for Infection Research (DZIF); Brunswick Germany

11. Department of Infectious Diseases and Respiratory Medicine; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

12. Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response (ZBS7), Clinical Management and Infection Control (ZBS7.1); Robert Koch Institute; Berlin Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference56 articles.

1. Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar;Abu-Raddad;New England Journal of Medicine,2022

2. Development of SARS-CoV-2 vaccines;Barajas-Nava;Boletín Médico del Hospital Infantil de México,2021

3. Basta NE Moodie EMM on behalf of the VIPER (Vaccines Infectious disease Prevention and Epidemiology Research) Group COVID-19 Vaccine Development and Approvals Tracker Team COVID-19 vaccine tracker covid19.trackvaccines.org/vaccines/

4. Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults;Brockmann;Journal of Infectious Diseases,2022

5. Centers for Disease Control and Prevention Joint statement from HHS Public Health and medical experts on COVID-19 booster shots www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development;Frontiers in Immunology;2023-11-23

2. Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals;Frontiers in Immunology;2023-11-02

3. COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study;Vaccines;2023-10-30

4. Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response;Life;2023-10-26

5. Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination;BMJ Open;2023-10